Clinical Characteristics, Drug Resistance, and Risk Factors for Death of Klebsiella pneumoniae Infection in Patients with Acute Pancreatitis: A Single-Center Retrospective Study from China

References

• Xiao AY, Tan ML, Wu LM, et al. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol. 2016;1(1):45–55. doi:10.1016/S2468-1253(16)30004-8
   PubMed Web of Science ®Google Scholar
• van Santvoort HC, Bakker OJ, Bollen TL, et al. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology. 2011;141(4):1254–1263. doi:10.1053/j.gastro.2011.06.073
   PubMed Web of Science ®Google Scholar
• Brown LA, Hore TA, Phillips AR, Windsor JA, Petrov MS. A systematic review of the extra-pancreatic infectious complications in acute pancreatitis. Pancreatology. 2014;14(6):436–443. doi:10.1016/j.pan.2014.09.010
   PubMed Web of Science ®Google Scholar
• van Brunschot S, Bakker OJ, Besselink MG, et al. Treatment of necrotizing pancreatitis. Clin Gastroenterol Hepatol. 2012;10(11):1190–1201. doi:10.1016/j.cgh.2012.05.005
   PubMed Web of Science ®Google Scholar
• Schmidt PN, Roug S, Hansen EF, Knudsen JD, Novovic S. Spectrum of microorganisms in infected walled-off pancreatic necrosis - impact on organ failure and mortality. Pancreatology. 2014;14(6):444–449. doi:10.1016/j.pan.2014.09.001
   PubMed Web of Science ®Google Scholar
• Ning C, Huang G, Shen D, et al. Adverse clinical outcomes associated with multidrug-resistant organisms in patients with infected pancreatic necrosis. Pancreatology. 2019;19(7):935–940. doi:10.1016/j.pan.2019.09.008
   PubMed Web of Science ®Google Scholar
• Effah CY, Sun T, Liu S, Wu Y. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob. 2020;19(1):1. doi:10.1186/s12941-019-0343-8
   PubMed Web of Science ®Google Scholar
• Wu D, Ding J, Jia Y, Liu H, Xiao J, Peng J. Predictors of mortality in acute pancreatitis complicated with multidrug-resistant Klebsiella pneumoniae infection. BMC Infect Dis. 2021;21(1):977. doi:10.1186/s12879-021-06709-0
   PubMed Web of Science ®Google Scholar
• Meinel T, Lerch C, Fischer U, et al. Multivariable prediction model for futile recanalization therapies in patients with acute ischemic stroke. Neurology. 2022;99(10):e1009–1018. doi:10.1212/WNL.0000000000200815
   PubMed Web of Science ®Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332. doi:10.1016/j.ajic.2008.03.002
   PubMed Web of Science ®Google Scholar
• Qin X, Wu S, Hao M, et al. The colonization of carbapenem-resistant Klebsiella pneumoniae: epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis. 2020;221(Suppl 2):S206–s214. doi:10.1093/infdis/jiz622
   PubMed Web of Science ®Google Scholar
• Yang X, Sun Q, Li J, et al. Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China. Emerg Microbes Infect. 2022;11(1):841–849. doi:10.1080/22221751.2022.2049458
   PubMed Web of Science ®Google Scholar
• Wu D, Xiao J, Ding J, et al. Predictors of mortality and drug resistance among carbapenem-resistant enterobacteriaceae-infected pancreatic necrosis patients. Infect Dis Ther. 2021;10(3):1665–1676. doi:10.1007/s40121-021-00489-5
   PubMed Web of Science ®Google Scholar
• Cheng MP, Stenstrom R, Paquette K, et al. Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: a diagnostic study. Ann Intern Med. 2019;171(8):547–554. doi:10.7326/M19-1696
   PubMed Web of Science ®Google Scholar
• Tian H, Chen L, Wu X, et al. Infectious complications in severe acute pancreatitis: pathogens, drug resistance, and status of nosocomial infection in a university-affiliated teaching hospital. Dig Dis Sci. 2020;65(7):2079–2088. doi:10.1007/s10620-019-05924-9
   PubMed Web of Science ®Google Scholar
• Wu D, Huang Y, Xiao J, Qin G, Liu H, Peng J. Risk factors for mortality among critical acute pancreatitis patients with carbapenem-resistant organism infections and drug resistance of causative pathogens. Infect Dis Ther. 2022;11(3):1089–1101. doi:10.1007/s40121-022-00624-w
   PubMed Web of Science ®Google Scholar
• Jin X, Chen Q, Shen F, et al. Resistance evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11 during treatment with tigecycline and polymyxin. Emerg Microbes Infect. 2021;10(1):1129–1136. doi:10.1080/22221751.2021.1937327
   PubMed Web of Science ®Google Scholar
• Cui N, Cai H, Li Z, Lu Y, Wang G, Lu A. Tigecycline-induced coagulopathy: a literature review. Int J Clin Pharm. 2019;41(6):1408–1413. doi:10.1007/s11096-019-00912-5
   PubMed Web of Science ®Google Scholar
• Murri R, Fiori B, Spanu T, et al. Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series. Infection. 2017;45(2):209–213. doi:10.1007/s15010-016-0968-x
   PubMed Web of Science ®Google Scholar
• Bassetti M, Righi E, Carnelutti A, Graziano E, Russo A. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Rev Anti Infect Ther. 2018;16(10):749–761. doi:10.1080/14787210.2018.1522249
   PubMed Web of Science ®Google Scholar
• Jayol A, Nordmann P, Poirel L, Dubois V. Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2018;73(2):542–544. doi:10.1093/jac/dkx393
   PubMed Web of Science ®Google Scholar
• García-Castillo M, García-Fernández S, Gómez-Gil R, et al. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain. Int J Antimicrob Agents. 2018;51(3):511–515. doi:10.1016/j.ijantimicag.2018.01.011
   PubMed Web of Science ®Google Scholar
• Rodríguez-Avial I, Pena I, Picazo JJ, Rodríguez-Avial C, Culebras E. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains. Int J Antimicrob Agents. 2015;46(6):616–621. doi:10.1016/j.ijantimicag.2015.07.021
   PubMed Web of Science ®Google Scholar
• Denervaud-Tendon V, Poirel L, Connolly LE, Krause KM, Nordmann P. Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates. J Antimicrob Chemother. 2017;72(10):2787–2791. doi:10.1093/jac/dkx239
   PubMed Web of Science ®Google Scholar
• Guo D, Dai W, Shen J, et al. Assessment of prophylactic carbapenem antibiotics administration for severe acute pancreatitis: an updated systematic review and meta-analysis. Digestion. 2022;103(3):183–191. doi:10.1159/000520892
   PubMed Web of Science ®Google Scholar
• Yan J, Yilin H, Di W, et al. A nomogram for predicting the risk of mortality in patients with acute pancreatitis and Gram-negative bacilli infection. Front Cell Infect Microbiol. 2022;12:1032375. doi:10.3389/fcimb.2022.1032375
   PubMed Web of Science ®Google Scholar
• Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi:10.1186/s12941-017-0191-3
   PubMed Web of Science ®Google Scholar
• Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. doi:10.1136/gutjnl-2012-302779
   PubMed Web of Science ®Google Scholar
• Evans RP, Mourad MM, Pall G, Fisher SG, Bramhall SR. Pancreatitis: preventing catastrophic haemorrhage. World J Gastroenterol. 2017;23(30):5460–5468. doi:10.3748/wjg.v23.i30.5460
   PubMed Web of Science ®Google Scholar
• Wei AL, Guo Q, Wang MJ, Hu WM, Zhang ZD. Early complications after interventions in patients with acute pancreatitis. World J Gastroenterol. 2016;22(9):2828–2836. doi:10.3748/wjg.v22.i9.2828
   PubMed Web of Science ®Google Scholar
• Andersson E, Ansari D, Andersson R. Major haemorrhagic complications of acute pancreatitis. Br J Surg. 2010;97(9):1379–1384. doi:10.1002/bjs.7113
   PubMed Web of Science ®Google Scholar
• Ammori BJ, Madan M, Alexander DJ. Haemorrhagic complications of pancreatitis: presentation, diagnosis and management. Ann R Coll Surg Engl. 1998;80(5):316–325.
   PubMed Web of Science ®Google Scholar
• Balthazar EJ, Fisher LA. Hemorrhagic complications of pancreatitis: radiologic evaluation with emphasis on CT imaging. Pancreatology. 2001;1(4):306–313. doi:10.1159/000055829
   PubMed Web of Science ®Google Scholar
• Labarca E, Zubia F, Maraví-Poma E, Martinez F. Early predictors of abdominal hemorrhage among critically Ill patients with pancreatitis: a prospective cohort study. Pancreas. 2018;47(8):1027–1032. doi:10.1097/MPA.0000000000001135
   PubMed Web of Science ®Google Scholar
• Flati G, Andrén-Sandberg A, La Pinta M, Porowska B, Carboni M. Potentially fatal bleeding in acute pancreatitis: pathophysiology, prevention, and treatment. Pancreas. 2003;26(1):8–14. doi:10.1097/00006676-200301000-00002
   PubMed Web of Science ®Google Scholar
• Gupta V, Krishna P, Kochhar R, et al. Hemorrhage complicating the course of severe acute pancreatitis. Ann Hepatobiliary Pancreat Surg. 2020;24(3):292–300. doi:10.14701/ahbps.2020.24.3.292
   PubMedGoogle Scholar
• Li X, Li L, Liu L, et al. Risk factors of multidrug resistant pathogens induced infection in severe acute pancreatitis. Shock. 2020;53(3):293–298. doi:10.1097/SHK.0000000000001371
   PubMed Web of Science ®Google Scholar
• Esposito S, De Simone G, Boccia G, De Caro F, Pagliano P. Sepsis and septic shock: new definitions, new diagnostic and therapeutic approaches. J Glob Antimicrob Resist. 2017;10:204–212. doi:10.1016/j.jgar.2017.06.013
   PubMed Web of Science ®Google Scholar
• Jia Y, Li Y, Liu Y, Yang Z, Chen X, Liu Y. Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients. Front Cell Infect Microbiol. 2022;12:1098856. doi:10.3389/fcimb.2022.1098856
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/S1473-3099(17)30753-3
   PubMed Web of Science ®Google Scholar
• Pupelis G. Renal failure in acute pancreatitis. Timing of dialysis and surgery. Przegl Lek. 2000;57 Suppl 5:29–31.
   PubMedGoogle Scholar
• Cao X, Wang HM, Lu R, et al. Establishment and verification of a nomogram for predicting severe acute pancreatitis. Eur Rev Med Pharmacol Sci. 2021;25(3):1455–1461. doi:10.26355/eurrev_202102_24853
   PubMed Web of Science ®Google Scholar
• Zou C, Lu Z, Zhang Z, et al. Factors associated with pancreatic infection in patients with severe acute pancreatisis. Int J Clin Exp Med. 2015;8(8):14100–14104.
   PubMed Web of Science ®Google Scholar
• Engoren M, Maile MD, Heung M, et al. The association between urine output, creatinine elevation, and death. Ann Thorac Surg. 2017;103(4):1229–1237. doi:10.1016/j.athoracsur.2016.07.036
   PubMed Web of Science ®Google Scholar